ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

Myriad In Partnership To Market Products.

December 14, 2001

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014